Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial. - Yuan, Meng-Qi; Song, Le; Wang, Ze-Rui; Zhang, Zi-Ying; Shi, Ming; He, Junli; Mo, Qiong; Zheng, Ning; Yao, Wei-Qi; Zhang, Yu; Dong, Tengyun; Li, Yuanyuan; et al. (Stem Cell Research & Therapy, 2025)